Imara Inc.

Imara Inc. 700 Technology Square, 3rd Floor Cambridge, MA 02139
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1672619

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Imara Inc. has not been involved in any litigation in the PlainSite database.

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (3)

	Last Name	First Name	Middle Name	Firm	Location
	DOCKETING	IP		Cooley LLP	Washington, DC
	Hiebert	Timothy	H.	macrae.ca Law Firm Placeholder	Boston, MA
	Pc	Dt	Ward		GROTON, MA

3 Rows Total

Filter By Form All Records D From To

	Date	Entity	Form Number	Description
	3/31/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/31/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/27/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	3/25/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/24/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/19/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	3/11/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	3/10/2026	Hohl Benjamin	4	Statement of changes in beneficial ownership of securities
	3/9/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/6/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	3/3/2026		S-8
	3/3/2026		8-K	Current report pursuant to Section 13 or 15(d)
	3/3/2026		10-K	Annual report pursuant to Section 13 or 15(d)
	2/19/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	2/19/2026	Heyman, Richard A.	4	Statement of changes in beneficial ownership of securities
	2/18/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	2/17/2026		SCHEDULE 13G
	2/17/2026	Patel, Anish	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Lyssikatos, Joseph P.	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Hohl Benjamin	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Derynck, Mika K.	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Collins Helen Louise	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Bauer Jake	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Heyman, Richard A.	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Gupta, Rishi	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Kunkel Lori Anne	4	Statement of changes in beneficial ownership of securities
	2/17/2026	Garland J. Scott	4	Statement of changes in beneficial ownership of securities
	2/17/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	2/17/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	2/17/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	2/10/2026	Lyssikatos, Joseph P.	4	Statement of changes in beneficial ownership of securities
	2/2/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/22/2026	Lyssikatos, Joseph P.	4	Statement of changes in beneficial ownership of securities
	1/22/2026	Heyman, Richard A.	4	Statement of changes in beneficial ownership of securities
	1/20/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/13/2026	Patel, Anish	4	Statement of changes in beneficial ownership of securities
	1/12/2026	Lyssikatos, Joseph P.	4	Statement of changes in beneficial ownership of securities
	1/12/2026	Heyman, Richard A.	4	Statement of changes in beneficial ownership of securities
	1/9/2026	Garland J. Scott	4	Statement of changes in beneficial ownership of securities
	1/9/2026	Garland J. Scott	3	Initial statement of beneficial ownership of securities
	1/9/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/9/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/9/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/8/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/8/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/8/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/8/2026		144	Notice of proposed sale of securities pursuant to Rule 144 under...
	1/7/2026		8-K	Current report pursuant to Section 13 or 15(d)
	12/23/2025	Lyssikatos, Joseph P.	4	Statement of changes in beneficial ownership of securities

718 Rows Total	Page 1 of 15 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	12/30/2024	Mcarthur, James	Assignor	Application Publication	18989150 20250120974	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/30/2024	Foo, Shi Yin	Assignor	Application Publication	18989150 20250120974	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/30/2024	Dehart, Michael Paul	Assignor	Application Publication	18989150 20250120974	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/30/2024	Calamai, Edward George	Assignor	Application Publication	18989150 20250120974	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/30/2024	Dobbins, Deborah Lynn Leithead	Assignor	Application Publication	18989150 20250120974	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/30/2024	Cardurion Pharmaceuticals, Inc.	Assignee	Application Publication	18989150 20250120974
	5/14/2024	Svenstrup, Niels	Assignor	Application Publication	18647249 20250019381
	5/14/2024	Cydan Development, Inc.	Assignor	Application Publication	18647249 20250019381
	5/14/2024	Wuxi Apptec (hong Kong) Ltd.	Assignor	Application Publication	18647249 20250019381	PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL... PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL...
	5/14/2024	Sta Pharmaceutical Hong Kong Ltd.	Assignor	Application Publication	18647249 20250019381	PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL... PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL...
	5/14/2024	Sta Pharmaceutical Hong Kong Ltd.	Assignor	Application Publication	18647249 20250019381	PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL... PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL...
	5/14/2024	Cardurion Pharmaceuticals, Inc.	Assignee	Application Publication	18647249 20250019381	PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL... PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL...
	3/21/2024	Cardurion Pharmaceuticals, Inc.	Assignee	Application Publication	18594898 20240199627	Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	3/21/2024	Johnson Matthey Plc.	Assignor	Application Publication	18594898 20240199627	Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	3/21/2024	Johnson Matthey Plc.	Assignor	Application Publication	18594898 20240199627	Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	3/21/2024	Sta Pharmaceutical Hong Kong Ltd.	Assignor	Application Publication	18594898 20240199627	Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	4/27/2023	Ballal, Rahul Dilip	Assignor	Application Publication	18033662 20240025904	Pde9 Inhibitors For Treating Cardiac Failure Pde9 Inhibitors For Treating Cardiac Failure
	4/27/2023	Maciel, Thiago Trovati	Assignor	Application Publication	18033662 20240025904	Pde9 Inhibitors For Treating Cardiac Failure Pde9 Inhibitors For Treating Cardiac Failure
	4/27/2023	Cardurion Pharmaceuticals, Inc.	Assignee	Application Publication	18033662 20240025904
	1/10/2023	Cardurion Pharmaceuticals, Inc.	Assignee	Application Application Application Application Application Publication Publication Publication Publication Publication	17493677 17067588 17186442 17110000 17514337 20210177845 20210107911 20220047589 20220023302 20210085684	Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Sickle Cell Disease Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Sickle Cell Disease Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	1/10/2023	Cardurion Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16615347 20200157108 11370795	PROCESS FOR THE SYNTHESIS OF 6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL... Methods Of Making And Using Pde9 Inhibitors Methods Of Making And Using Pde9 Inhibitors
	1/10/2023	Cardurion Pharmaceuticals, Inc.	Assignee	Application Application Application Application Application Publication Publication Publication Publication Publication Patent Patent	17110000 17493677 17186442 17514337 17067588 20210085684 20210107911 20220023302 20210177845 20220047589 12006319 12213975	Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treating Sickle Cell Disease Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	1/5/2022	Johnson Matthey Plc.	Assignor	Application Publication	17110000 20210107911	Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-... Monohydrate And Crystalline Forms Of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-...
	12/14/2021	Svenstrup, Niels	Assignor	Application Publication	17493677 20220023302	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/14/2021	Senopsys LLC	Assignor	Application Publication	17493677 20220023302	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	11/3/2021	Ballal, Rahul Dilip	Assignor	Application Publication	17514337 20220047589	Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Thalassemia
	11/3/2021	Maciel, Thiago Trovati	Assignor	Application Publication	17514337 20220047589	Pde9 Inhibitors For Treating Thalassemia Pde9 Inhibitors For Treating Thalassemia
	3/31/2021	Mcarthur, James	Assignor	Application Publication Patent	17186442 20210177845 12213975	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	3/31/2021	Foo, Shi Yin	Assignor	Application Publication Patent	17186442 20210177845 12213975	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	3/31/2021	Dehart, Michael Paul	Assignor	Application Publication Patent	17186442 20210177845 12213975	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	3/31/2021	Calamai, Edward George	Assignor	Application Publication Patent	17186442 20210177845 12213975	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	3/31/2021	Dobbins, Deborah Lynn Leithead	Assignor	Application Publication Patent	17186442 20210177845 12213975	Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease Pde9 Inhibitors For Treating Sickle Cell Disease
	12/21/2020	Complexa, Inc.	Assignor	Application Publication	16657028 20200046669	Treatment Of Pulmonary Arterial Hypertension Using Therapeutically Effec... Treatment Of Pulmonary Arterial Hypertension Using Therapeutically Effec...
	12/17/2020	Complexa, Inc.	Assignor	Application Publication Patent	15283887 20170095437 10537541	Treatment Of Focal Segmental Glomerular Sclerosis (fsgs) Using Therapeut... Treatment Of Focal Segmental Glomerular Sclerosis (fsgs) Using Therapeut... Treatment Of Focal Segmental Glomerular Sclerosis (fsgs) Using Therapeut...
	10/16/2020	Mcarthur, James	Assignor	Application Publication	17067588 20210085684	Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treatment Of Peripheral Diseases
	10/16/2020	Mcarthur, James	Assignor	Application Publication	17067588 20210085684	Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treatment Of Peripheral Diseases
	10/16/2020	Mcarthur, James	Assignor	Application Publication	17067588 20210085684	Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treatment Of Peripheral Diseases
	6/24/2020	Cydan Development, Inc.	Assignor	Application Publication	16615347 20200157108	Methods Of Making And Using Pde9 Inhibitors Methods Of Making And Using Pde9 Inhibitors
	6/24/2020	Svenstrup, Niels	Assignor	Application Publication	16615347 20200157108	Methods Of Making And Using Pde9 Inhibitors Methods Of Making And Using Pde9 Inhibitors
	6/24/2020	Sta Pharmaceutical Hong Kong Ltd.	Assignor	Application Publication	16615347 20200157108	Methods Of Making And Using Pde9 Inhibitors Methods Of Making And Using Pde9 Inhibitors
	6/24/2020	Wuxi Apptec (hong Kong ) Ltd.	Assignor	Application Publication	16615347 20200157108	Methods Of Making And Using Pde9 Inhibitors Methods Of Making And Using Pde9 Inhibitors
	1/30/2019	Mcarthur, James	Assignor	Application Publication	16315365 20190307754	Pde9 Inhibitors For Treatment Of Peripheral Diseases Pde9 Inhibitors For Treatment Of Peripheral Diseases
	1/30/2019	Mcarthur, James	Assignor	Application Publication	16315365 20190307754
	1/30/2019	Mcarthur, James	Assignor	Application Publication	16315365 20190307754

44 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	0
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86725690
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	0
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86824860
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86824860
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	5125282
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86725690
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	0
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86824860
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	5125282
	11/4/2016	Cydan Development, Inc.	Assignor	Application	86725690
	11/4/2016	Cydan Development, Inc.	Assignor	Trademark	5130221

12 Rows Total

Competitors (0)

There are no organizations to display.

Corporate Family (51)

Track Corporate Family

• Adams Christoph M, None
• Agger Mette Kirstine, None
• Alexandria Venture Investments, LLC, None
• Arix Bioscience Holdings Ltd, None
• Arix Bioscience plc, None
• Attie, Kenneth, None
• Ballal Rahul D., None
• Bauer Jake, None
• Bay City Capital Fund LLC, None
• Bay City Capital Fund V Co-investment Fund, LP, None
• Bonita David P, None
• Chin Mark, None
• Collins Helen Louise, None
• Commodore Capital Lp, None
• Conner Edward R., None
• Dalton Barbara, None
• Derynck, Mika K., None
• Fair Richard A., None
• Garland J. Scott, None
• Goldfischer Carl, None
• Gray, Michael, None
• Gupta, Rishi, None
• H. Lundbeck A/s, None
• Heyman, Richard A., None
• Hohl Benjamin, None
• Kerins Patrick J, None
• Kintz, Samuel, None
• Kunkel Lori Anne, None
• Leonard Braden Michael, None
• Lundbeckfond Invest A/s, None
• Lyssikatos, Joseph P., None
• Mcarthur, James G., None
• Mott, David M., None
• Nayeem Sara M., None
• New Enterprise Associates 14 L.p., None
• Orbimed Advisors, LLC, None
• OrbiMed Capital GP VII LLC, None
• Parmar, Kush, None
• Patel, Anish, None
• Pfizer Ventures (US) LLC, None
• Pfizer, Inc., None
• Phillips, Andrew John, None
• RA Capital Biotech Fund LP, None
• Ra Capital Management, LLC, None
• Rock Springs Capital LLC, None
• Rock Springs Capital Master Fund LP, None
• Ruthigen, Inc., None
• Scheele Willem, None
• Schwab, Andrew J., None
• Sensus Healthcare, LLC, None
• Williams, Laura A., None

Subsidiaries

• Conner Edward R.
• Pfizer Ventures (US) LLC
• Alexandria Venture Investments, LLC
• H. Lundbeck A/s
• Arix Bioscience Holdings Ltd
• Rock Springs Capital LLC
• OrbiMed Capital GP VII LLC
• Lundbeckfond Invest A/s
• Bay City Capital Fund V Co-investment Fund, LP
• Mcarthur, James G.
• Chin Mark
• Agger Mette Kirstine
• Bonita David P
• Dalton Barbara
• New Enterprise Associates 14 L.p.
• Nayeem Sara M.
• Mott, David M.
• Ra Capital Management, LLC
• Gray, Michael
• Ballal Rahul D.
• Attie, Kenneth
• Pfizer, Inc.
• Adams Christoph M
• Scheele Willem
• Bay City Capital Fund LLC
• Goldfischer Carl
• Arix Bioscience plc
• Orbimed Advisors, LLC
• Rock Springs Capital Master Fund LP
• Sensus Healthcare, LLC
• Ruthigen, Inc.
• Kerins Patrick J
• Leonard Braden Michael
• Williams, Laura A.
• RA Capital Biotech Fund LP
• Commodore Capital Lp
• Kintz, Samuel
• Collins Helen Louise
• Hohl Benjamin
• Lyssikatos, Joseph P.
• Patel, Anish
• Bauer Jake
• Derynck, Mika K.
• Gupta, Rishi
• Phillips, Andrew John
• Schwab, Andrew J.
• Heyman, Richard A.
• Parmar, Kush
• Kunkel Lori Anne
• Fair Richard A.
• Garland J. Scott

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.